Search - tctmd.com

Displaying 221 - 240 of 479

Sort: Relevancy | Date

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Daily News

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

L.A. McKeown

July 01, 2015

Presentation

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Presenter: Fernando Alfonso

June 30, 2015

Presentation

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

Presenter: Seiji Habara

June 30, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

Presentation CCVVC 2015

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Presenter: Craig M. Walker

June 18, 2015

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Todd Neale

June 08, 2015

News Daily News

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

L.A. McKeown

June 03, 2015

Presentation

Long-term Efficacy and Safety of Paclitaxel-Eluting Balloon (PEB) for the Treatment of DES Restenosis

Presenter: Sebastian Kufner

June 02, 2015

Advertisement

Symic Biomedical Selects Vascular Clinical Candidate

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

U.S. to vie with India for top bioabsorbable stent market after FDA approval

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

Meta-analysis Confirms Late Safety of Second-Generation DES

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

Long-term Efficacy and Safety of Paclitaxel-Eluting Balloon (PEB) for the Treatment of DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content